Version 2.77

Part Descriptions

LP173592-9   Adalimumab
Adalimumab is a human monoclonal antibody that binds tumor necrosis factor alpha (TNFα). TNFα is a cell signaling protein that, when present in excess, may lead to the development of inflammatory immune diseases including Crohn's disease, rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Adalimumab inactivates TNFα by binding to the TNFα receptor. PMID: 23943614 Treatment with adalimumab does not necessitate laboratory monitoring though association with increased transamines and pancytopenia may argue for intermittant blood cell counts and liver function tests. Adalimumab has been associated with serious infections including the reactivation of tuberculosis and deep fungal infections as well as other rare side effects, including lymphoma, heart failure and demyelinating disease. PMID: 16011443 Source: Regenstrief LOINC

LP173593-7   Adalimumab Ab
Antibodies to adalimumab were shown to develop in 67% of patients within the first 28 weeks of treatment. Only thirteen percent of patients with adalimumab antibodies experienced relief from symptoms compared to 48% of patients without antibodies to adalimumab. Only 4% of patients with antibodies went into remission compared to 34% of patients who achieved remission without anti-adalimumab antibodies. Antibodies to adalimumab reduced the likelihood that patients would have relief from disease symptoms or go into remission. PMID: 21486979 Source: Regenstrief LOINC

Fully-Specified Name

Component
Adalimumab Ab
Property
ACnc
Time
Pt
System
Ser/Plas
Scale
Qn
Method

Additional Names

Short Name
Adalimumab Ab SerPl-aCnc
Display Name
Adalimumab Ab Qn
Consumer Name Alpha Get Info
Adalimumab antibody, Blood

Basic Attributes

Class
SERO
Type
Laboratory
First Released
Version 2.63
Last Updated
Version 2.73
Order vs. Observation
Both
Common Test Rank Get Info
6608

Member of these Groups Get Info

LOINC Group Group Name
LG50118-5 Adalimumab Ab|ACnc|Pt|ANYBldSerPl

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Adalimumab Anticuerpos:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:
Synonyms: Cuantitativo
es-MX Spanish (Mexico) Adalimumab Ab:Concentración arbitraria:Punto temporal:Suero o Plasma:Cuantitativo:
fr-FR French (France) Adalimumab anticorps:Arbitraire/Volume:Ponctuel:Sérum/Plasma:Numérique:
it-IT Italian (Italy) Adalimumab Ab:ACnc:Pt:Siero/Plasma:Qn:
Synonyms: anticorpo Concentrazione Arbitraria Plasma Punto nel tempo (episodio) Siero Siero o Plasma Sierologia (anticorpi e la maggior parte degli ant
nl-NL Dutch (Netherlands) adalimumab As:eenheid/volume:moment:serum of plasma:kwantitatief:
Synonyms: antistof; antilichaam
ru-RU Russian (Russian Federation) Адалимумаб Ат:ПроизвКонц:ТчкВрм:Сыв/Плаз:Колич:
Synonyms: Антитело Количественный Плазма Произвольная концентрация Сыворотка Сыворотка или Плазма Точка во времени;Момент
tr-TR Turkish (Turkey) Adalimumab Ab:SçKons:Zmlı:Ser/Plaz:Kant:
Synonyms: Ak
zh-CN Chinese (China) 阿达木单抗 抗体:任意型浓度:时间点:血清/血浆:定量型:
Synonyms: Ab;自身抗体 Adalimumab 单抗;人体抗肿瘤坏死因子-α单克隆抗体;阿达莫单抗;阿达木;阿达莫;阿达木单克隆抗体 任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 血清;血清学;血清学检验项目;血清学检验项目 (非微生物学);血清学检验项目（非微生物学）;血清学检验项目类;血清学检验项目类 (非微生物学);血清学类;血清学类检验项目;血清学类检验项目 (非微生物学);血清学类试验;血清学类试验 (非微生物学);血清学试验;血清学试验 (非微生物学);血清学试验（非微生物学）;血清学试验类 (非微生物学);血清类 血清或血浆

Example Units

Unit Source
[arb'U]/mL Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=87742-3